ITMI910314A0 - Plasmide pctd isolato da chlamydia trachomatis serotipo d, suoi geni e proteine da essi codificate; plasmidi ricombinanti per l'espressionedi detti geni in sistemi eterologhi come proteine ricombinanti di fusione, preparazione di dette proteine ricombinanti e loro uso nella formulazione di vaccini e/o diagnostici - Google Patents

Plasmide pctd isolato da chlamydia trachomatis serotipo d, suoi geni e proteine da essi codificate; plasmidi ricombinanti per l'espressionedi detti geni in sistemi eterologhi come proteine ricombinanti di fusione, preparazione di dette proteine ricombinanti e loro uso nella formulazione di vaccini e/o diagnostici

Info

Publication number
ITMI910314A0
ITMI910314A0 IT91MI314A ITMI910314A ITMI910314A0 IT MI910314 A0 ITMI910314 A0 IT MI910314A0 IT 91MI314 A IT91MI314 A IT 91MI314A IT MI910314 A ITMI910314 A IT MI910314A IT MI910314 A0 ITMI910314 A0 IT MI910314A0
Authority
IT
Italy
Prior art keywords
recombinant
proteins
genes
pctd
vaccines
Prior art date
Application number
IT91MI314A
Other languages
English (en)
Inventor
Giulio Ratti
Maurizio Comanducci
Mario Felice Tecce
Marzia Giuliani
Original Assignee
Sclavo Spa
Scavo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sclavo Spa, Scavo filed Critical Sclavo Spa
Publication of ITMI910314A0 publication Critical patent/ITMI910314A0/it
Priority to ITMI910314A priority Critical patent/IT1244706B/it
Priority to ES91106110T priority patent/ES2136062T3/es
Priority to AT91106110T priority patent/ATE181104T1/de
Priority to DE69131319T priority patent/DE69131319T2/de
Priority to EP91106110A priority patent/EP0499681B1/en
Priority to DK91106110T priority patent/DK0499681T3/da
Publication of ITMI910314A1 publication Critical patent/ITMI910314A1/it
Application granted granted Critical
Publication of IT1244706B publication Critical patent/IT1244706B/it
Priority to US08/444,189 priority patent/US6110705A/en
Priority to US08/468,544 priority patent/US6248563B1/en
Priority to US08/969,644 priority patent/US6096519A/en
Priority to GR990401491T priority patent/GR3030447T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/125—Gram-negative bacteria from Chlamydiales (O)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ITMI910314A 1991-02-07 1991-02-07 Plasmide pctd isolato da chlamydia trachomatis serotipo d, suoi geni e proteine da essi codificate; plasmidi ricombinanti per l'espressionedi detti geni in sistemi eterologhi come proteine ricombinanti di fusione, preparazione di dette proteine ricombinanti e loro uso nella formulazione di vaccini e/o diagnostici IT1244706B (it)

Priority Applications (10)

Application Number Priority Date Filing Date Title
ITMI910314A IT1244706B (it) 1991-02-07 1991-02-07 Plasmide pctd isolato da chlamydia trachomatis serotipo d, suoi geni e proteine da essi codificate; plasmidi ricombinanti per l'espressionedi detti geni in sistemi eterologhi come proteine ricombinanti di fusione, preparazione di dette proteine ricombinanti e loro uso nella formulazione di vaccini e/o diagnostici
EP91106110A EP0499681B1 (en) 1991-02-07 1991-04-17 PCTD plasmid isolated from chlamydia trachomatis serotype D, its genes and proteins encoded by them; recombinant plasmids for the expression of said genes in heterologous systems as fused recombinant proteins, preparation of said recombinant proteins and their use in the formulation of vaccines and/or dianostics
AT91106110T ATE181104T1 (de) 1991-02-07 1991-04-17 Isoliertes pctd plasmid aus chlamydia trachomatis von serotyp d, dessen genen und davon kodierten proteine, rekombinante plasmide für die expression von deren genen als fusionsproteine in einem keterologen system, und ihre verwendung als impfstoff- und/oder diagnostiekformulierung
DE69131319T DE69131319T2 (de) 1991-02-07 1991-04-17 Isoliertes PCTD Plasmid aus Chlamydia trachomatis von Serotyp D, dessen Genen und davon kodierten Proteine, rekombinante Plasmide für die Expression von deren Genen als Fusionsproteine in einem keterologen System, und ihre Verwendung als Impfstoff- und/oder Diagnostiekformulierung
ES91106110T ES2136062T3 (es) 1991-02-07 1991-04-17 Plasmido pctd aislado de chlamydia trachomatis serotipo d, genes y proteinas codificados por el mismo; plasmidos recombinantes para la expresion de dichos genes en sistemas heterologos como proteinas recombinantes de fusion, preparacion de dichas proteinas recombinantes y ...
DK91106110T DK0499681T3 (da) 1991-02-07 1991-04-17 pCTD-plasmid isoleret fra Chlamydia trachomatis serotype D, dets gener og proteiner, som kodes af dem; rekombinante plasmid
US08/444,189 US6110705A (en) 1991-02-07 1995-05-18 Recombinant Chlamydia trachomatis pgp3 fusion protein
US08/468,544 US6248563B1 (en) 1991-02-07 1995-06-06 Chlamydia trachomatis serotype D genes
US08/969,644 US6096519A (en) 1991-02-07 1997-11-13 Chlamydia trachomatis serotype D proteins
GR990401491T GR3030447T3 (en) 1991-02-07 1999-06-10 PCTD plasmid isolated from chlamydia trachomatis serotype D, its genes and proteins encoded by them; recombinant plasmids for the expression of said genes in heterologous systems as fused recombinant proteins, preparation of said recombinant proteins and their use in the formulation of vaccines and/or dianostics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI910314A IT1244706B (it) 1991-02-07 1991-02-07 Plasmide pctd isolato da chlamydia trachomatis serotipo d, suoi geni e proteine da essi codificate; plasmidi ricombinanti per l'espressionedi detti geni in sistemi eterologhi come proteine ricombinanti di fusione, preparazione di dette proteine ricombinanti e loro uso nella formulazione di vaccini e/o diagnostici

Publications (3)

Publication Number Publication Date
ITMI910314A0 true ITMI910314A0 (it) 1991-02-07
ITMI910314A1 ITMI910314A1 (it) 1992-08-07
IT1244706B IT1244706B (it) 1994-08-08

Family

ID=11358472

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI910314A IT1244706B (it) 1991-02-07 1991-02-07 Plasmide pctd isolato da chlamydia trachomatis serotipo d, suoi geni e proteine da essi codificate; plasmidi ricombinanti per l'espressionedi detti geni in sistemi eterologhi come proteine ricombinanti di fusione, preparazione di dette proteine ricombinanti e loro uso nella formulazione di vaccini e/o diagnostici

Country Status (8)

Country Link
US (2) US6110705A (it)
EP (1) EP0499681B1 (it)
AT (1) ATE181104T1 (it)
DE (1) DE69131319T2 (it)
DK (1) DK0499681T3 (it)
ES (1) ES2136062T3 (it)
GR (1) GR3030447T3 (it)
IT (1) IT1244706B (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629167A (en) * 1994-04-19 1997-05-13 Biocine S.P.A. Detection of antibodies against Chlamydia trachomatis pgp3 antigen in patient sera by enzyme-linked immunosorbent assay
US5814490A (en) * 1996-06-11 1998-09-29 Becton, Dickinson And Company Amplification and detection of chlamydia trachomatis nucleic acids
IL119938A (en) * 1996-12-30 2005-08-31 Yissum Res Dev Co Peptides capable of eliciting protective immunity against toxic shock induced by pyrogenic exotoxins or of antagonizing toxin-mediated activation of t cells
GB9828000D0 (en) 1998-12-18 1999-02-10 Chiron Spa Antigens
US7090973B1 (en) * 1999-04-09 2006-08-15 Oscient Pharmaceuticals Corporation Nucleic acid sequences relating to Bacteroides fragilis for diagnostics and therapeutics
GB0016814D0 (en) 2000-07-07 2000-08-30 Lee Helen Improved dipstick assays (3)
CN100515494C (zh) 2001-12-12 2009-07-22 启龙有限公司 抗沙眼衣原体的免疫
JP2010526070A (ja) * 2007-05-01 2010-07-29 ザ ボード オブ リージェンツ オブ ザ ユニバーシティ オブ テキサス システム Ｃｈｌａｍｙｄｉａ感染及び疾患の診断ならびに治療のための薬剤としてのＣｈｌａｍｙｄｉａ抗原
EP2342215A4 (en) 2008-10-09 2012-06-27 Univ Texas METHOD AND COMPOSITION FOR CHLAMYDIA ANTIGEN FOR THE DIAGNOSIS AND TREATMENT OF CHLAMYDIA INFECTION AND DETECTION

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0192033B1 (en) * 1985-01-14 1996-09-25 Chiron Corporation Chlamydia major outer membrane protein
GB8709746D0 (en) * 1987-04-24 1987-05-28 Wenman W M Chlamydia vaccine
IT1224253B (it) * 1988-04-08 1990-09-26 Sclavo Spa Oligonucleotidi sintetici utili per la determinazione di chlamydia trachomatis in un campione biologico

Also Published As

Publication number Publication date
IT1244706B (it) 1994-08-08
US6096519A (en) 2000-08-01
US6110705A (en) 2000-08-29
DE69131319T2 (de) 1999-12-16
ES2136062T3 (es) 1999-11-16
DK0499681T3 (da) 1999-11-15
ITMI910314A1 (it) 1992-08-07
ATE181104T1 (de) 1999-06-15
GR3030447T3 (en) 1999-09-30
DE69131319D1 (de) 1999-07-15
EP0499681B1 (en) 1999-06-09
EP0499681A1 (en) 1992-08-26

Similar Documents

Publication Publication Date Title
AU4306896A (en) Method for the preparation of a viral vector by intermolecular homologous recombination
KR970009347B1 (en) Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3
EP1433855A3 (en) Plasmids suitable for il-2 expression
CA2187974A1 (en) Newcastle disease virus combination vaccine
FR2676072B1 (fr) Vecteur de delivrance d'arn.
ITMI910314A0 (it) Plasmide pctd isolato da chlamydia trachomatis serotipo d, suoi geni e proteine da essi codificate; plasmidi ricombinanti per l'espressionedi detti geni in sistemi eterologhi come proteine ricombinanti di fusione, preparazione di dette proteine ricombinanti e loro uso nella formulazione di vaccini e/o diagnostici
DE3878468D1 (de) Chimarenglykoproteine, enthaltend immunogene segmente des humanen respiratorischen synzytialvirus.
AR023044A1 (es) Composicion farmaceutica soluble en agua en un complejo no ionico y uso del mismo
CA2241247A1 (en) Archaeosomes, archaeosomes containing coenzyme q10, and other types of liposomes containing coenzyme q10 as adjuvants and as delivery vehicles
DK0749317T3 (da) Terapeutiske anvendelser af dimerprodukter af baktericidt/permeabilitetsforøgende protein
DE69322092D1 (de) Neue bakterielle impfstoffe unter verwendung von impfstämmen von pathogenen bakterien
EP0319570A4 (en) Recombinant human cytomegalovirus containing foreign gene and use thereof
WO1996003506A3 (en) Analog of haemophilus hin47 with reduced protease activity
IL100115A0 (en) Isonicotinic acid derivatives and related spirocompounds,their preparation and their use as herbicides
AU4090393A (en) Fowl mycoplasma antigen, gene thereof, recombinant vector containing said gene, and vaccine prepared by utilizing the same
AU1668197A (en) Recombinant attentuated canrypox ALVAC virus expression vectors containing heterologous DNA segments encoding malarial gene products
ES513947A0 (es) Procedimiento para la preparacion de un vector hibrido y la clonacion de adn-ajeno en organismos hospetantes.
CA2188293A1 (fr) Herpesvirus transformes pour exprimer gd in vitro
ITRM910474A0 (it) Vettori plasmidici per l'espressione di geni in piante.
WO2001079473A3 (en) 21953, a human prolyl oligopeptidase family member and uses thereof
EE9400439A (et) Naftüridiini derivaadid, nende valmistamise meetodid, neid sisaldavad ravimvormid, eriti kasutamiseks antiproliferatiivsete preparaatidena
ITMI940727A0 (it) Vettore plasmidico e suo impiego per la produzione di proteine eterologhe
WO2002010391A3 (en) 18610, a human transient receptor and uses thereof
EP0722714A3 (en) Benzoxazole derivatives, the use thereof as sunscreens and cosmetic compositions containing them
Levy Survival of plasmids in Escherichia coli.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970226